dihydroxyphenylalanine has been researched along with Corneal Opacity in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Corneal Opacity: Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotzias, GC | 1 |
| Miller, ST | 1 |
| Nicholson, AR | 1 |
| Maston, WH | 1 |
| Tang, LC | 1 |
1 other study available for dihydroxyphenylalanine and Corneal Opacity
| Article | Year |
|---|---|
Prolongation of the life-span in mice adapted to large amounts of L-dopa.
Topics: Animals; Corneal Opacity; Diet; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Female; Lo | 1974 |